跳至主要内容
临床试验/IRCT2015020921017N1
IRCT2015020921017N1已完成1 期

Comparing the impacts of Doxycycline and placebo added to intraocular Bevacizumab on required numbers of injection and therapeutic progress in patients suffering from exudative Age related Macular Degeneration.

Vice Chancellor for Research and Technology, Tehran University of Medical Sciences0 个研究点目标入组 300 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
50 years 至 no limit(—)
性别
All

入选标准

  • occult choroidal neovascularization (classic CNV); subfoveal age related macular degeneration; naïve patients; central retinal thickness plus subfoveal fluid = 500 µm; lesion size = 2 Disk Diameter; no history for neither systemic disease nor myocardial infarction
  • Exclusion criteria: vitreomacular adhesion; fibrovascular scar; geographic atrophy; history of intraocular pressure rise.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research and Technology, Tehran University of Medical Sciences

相似试验